Japan, Aug. 6 -- JOINT STOCK COMPANY BIOCAD has got intellectual property rights for 'AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI IL17A ANTIBODY, AND USE OF THE SAME.' Other related details are as follows:
Application Number: JP,2024-080645
Category (FI): A61K47/26,A61K47/12,A61P37/02,A61P27/00,A61K9/08,A61K39/395@D,A61K39/395@N,A61K47/10,A61P29/00,C12N15/13,C07K16/24,A61P25/00,A61P17/00,A61P11/00,A61P43/00,111,A61P19/00,A61P1/00,A61P3/00,A61P35/00,A61P35/02,A61P37/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: May 17, 2024
Publication Date: Sept. 3, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....